Showing results (101-110 of 117) with videos related to
Sort By:
Pageof 12
Antiviral Research|December 15, 2022
Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical diseaseStephen R Welch, Jana M Ritter, Amy J Schuh, et al.Antiviral Research|November 14, 2024
Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral ResearchStephen R Welch, John P Bilello, Kara Carter, et al.Zoonoses and Public Health|April 15, 2022
Transmission of SARS-CoV-2 Delta variant (B.1.617.2) from a fully vaccinated human to a canine in Georgia, July 2021Natalie M Wendling, Ann Carpenter, Amanda Liew, et al.JCI Insight|December 12, 2022
Severe acute respiratory disease in American mink experimentally infected with SARS-CoV-2Danielle R Adney, Jamie Lovaglio, Jonathan E Schulz, et al.Science Advances|August 4, 2023
Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccinationStephen R Welch, Jessica R Spengler, Sarah C Genzer, et al.Nature Communications|November 26, 2022
Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virusIan A Durie, Zahra R Tehrani, Elif Karaaslan, et al.Viruses|January 21, 2023
One Health Investigation of SARS-CoV-2 in People and Animals on Multiple Mink Farms in UtahCaitlin M Cossaboom, Natalie M Wendling, Nathaniel M Lewis, et al.Biology|September 28, 2021
Low SARS-CoV-2 Seroprevalence and No Active Infections among Dogs and Cats in Animal Shelters with Laboratory-Confirmed COVID-19 Human Cases among EmployeesCaitlin M Cossaboom, Alexandra M Medley, Jessica R Spengler, et al.Viruses|September 28, 2021
One Health Investigation of SARS-CoV-2 Infection and Seropositivity among Pets in Households with Confirmed Human COVID-19 Cases-Utah and Wisconsin, 2020Grace W Goryoka, Caitlin M Cossaboom, Radhika Gharpure, et al.Science Translational Medicine|November 20, 2024
Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal diseaseStephen R Welch, Jessica R Spengler, Jonna B Westover, et al.Pageof 12